It was reported to gore that the patient underwent endovascular treatment for an unknown application with a gore® viabahn® endoprosthesis with propaten bioactive surface (vsx-device).The physician stated that when the device was removed from the packaging it was highlighted to him by his scrub nurse that the front tapered end of the delivery catheter was angulated at 30 - 40 degrees and she was having difficulty loading it on the wire.This end remained attached but was flexible relative to the rest of the delivery catheter.Given the lack of suitable alternatives, he decided to proceed with the device and there was no problem with deployment.Problems only arose when he attempted to remove the catheter and he could feel something snap as pulled the proximal end of the catheter through the haemostatic valve.Thankfully this was recognized immediately, sheaths were exchanged, and the front end of the catheter was retrieved from inside the sheath.He honestly don't know if this was a device or handling issue.
|
A1: no patient specific details have been provided.Therefore, the patient initials reflect internal case number.A2/a3/a4: no patient details were provided.B7: no patient history was provided.H3 other code: as the device remains implanted, no further investigation of the device can be performed.The delivery catheter will be returned for further evaluation.H6 evaluation codes investigation findings c19 refers to the product history review: a review of the manufacturing records indicated the device met pre-release specifications.Heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|